FDA Reconsidering Safety Training for Doctors Prescribing Opioids

Share this content:
FDA Reconsidering Training for Doctors Prescribing Opioids
FDA Reconsidering Training for Doctors Prescribing Opioids

(HealthDay News) -- Mandatory safety training for doctors who prescribe opioids is being reconsidered by the U.S. Food and Drug Administration.

Next week, an FDA committee of outside experts will meet to review risk-management plans introduced nearly four years ago in an effort to reduce misuse of opioids responsible for a national crisis of abuse and death, The Associated Press reported.

Under current programs, drug companies fund voluntary training for doctors on how to safely prescribe these medications, but many experts -- including a previous FDA advisory committee -- believe such training should be mandatory. The FDA's own investigations "show mixed results that make it difficult to draw conclusions regarding the success of the program," according to briefing documents posted online, the AP reported.

The FDA will present its findings at the two-day meeting, which begins Tuesday. The advisory panel will consider the issue and make recommendations about the doctor training program. The FDA does not have to follow the panel's advice.

More Information

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs